THAR Stock Analysis: Buy, Sell, or Hold?
THAR - Tharimmune, Inc. Common Stock
$4.74
0.26 (5.80%)
â˛
5d:
+8.47%
30d:
+60.14%
90d:
+57.48%
WAIT
LOW Confidence
Analysis Updated: Feb 17, 2026 12:00 AM ET
Earnings: Mar 24, 2026
0d
Get Alerted When THAR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: THAR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: THAR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: THAR is currently trading at $4.74, which is considered fair based on recent price action.
Technical Outlook: Technically, THAR is in a uptrend. Immediate support is located at $3.82, while resistance sits at $5.80. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, THAR is in a uptrend. Immediate support is located at $3.82, while resistance sits at $5.80. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
38/100
(SELL)
Volume Confirmation
UNKNOWN
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: Strong upward momentum (+5.8%)
- NEUTRAL: Near Wall St target ($5.00)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Support & Resistance Levels
Support Level
$3.82
Resistance Level
$5.80
Current Trend
Uptrend
Technical data as of
Feb 17, 2026
Fundamental Context
Wall Street Target
$5.00
(+5.5%)
Share & Embed Analysis
Last updated: August 25, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THAR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 38 SELL |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
